Flavopiridol in Treating Patients With Recurrent Prostate Cancer

NCT00003256 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: alvocidib

Sponsor

National Cancer Institute (NCI)